Cohen Neil Harris
SEC insider (Form 3/4/5 filer). CIK 0001840006. Director at Chemomab Therapeutics Ltd. (CMMB). 9 reported Form 4/5 transactions since Sep 2024; latest on Aug 28, 2026. Located in CAMBRIDGE, MA.
Companies Cohen Neil Harris has filed insider reports for
- Chemomab Therapeutics Ltd. (CMMB): Director
Cohen Neil Harris
CIK: 0001840006
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Chemomab Therapeutics Ltd.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Aug 28, 2026CMMB
Chemomab Therapeutics Ltd.
SaleDirect1K shares at avg. $2.80$3K - Aug 27, 2026CMMB
Chemomab Therapeutics Ltd.
SaleDirect1.3K shares at avg. $2.85$4K - Mar 16, 2026CMMB
Chemomab Therapeutics Ltd.
AwardDirectStock option (right to buy American Depositary Shares)
5.2K shares- - Mar 16, 2025CMMB
Chemomab Therapeutics Ltd.
AwardDirectStock option (right to buy American Depositary Shares)
3.8K shares- - Mar 18, 2024CMMB
Chemomab Therapeutics Ltd.
AwardDirectStock option (right to buy American Depositary Shares)
2.5K shares- - Mar 21, 2023CMMB
Chemomab Therapeutics Ltd.
AwardDirectStock option (right to buy American Depositary Shares)
1.7K shares- - Mar 7, 2022CMMB
Chemomab Therapeutics Ltd.
AwardDirectStock option (right to buy American Depositary Shares)
1.7K shares- - Apr 19, 2021CMMB
Chemomab Therapeutics Ltd.
AwardDirectStock option (right to buy American Depositary Shares)
3K shares- - Jul 16, 2020CMMB
Chemomab Therapeutics Ltd.
AwardDirectStock option (right to buy American Depositary Shares)
172 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 28, 2026 | CMMB Chemomab Therapeutics Ltd. | Sale | 1,000 | $2.80 | $2,800 | Direct |
| Aug 27, 2026 | CMMB Chemomab Therapeutics Ltd. | Sale | 1,304 | $2.85 | $3,716 | Direct |
| Mar 16, 2026 | CMMB Chemomab Therapeutics Ltd. | Award Stock option (right to buy American Depositary Shares) | 5,172 | - | - | Direct |
| Mar 16, 2025 | CMMB Chemomab Therapeutics Ltd. | Award Stock option (right to buy American Depositary Shares) | 3,821 | - | - | Direct |
| Mar 18, 2024 | CMMB Chemomab Therapeutics Ltd. | Award Stock option (right to buy American Depositary Shares) | 2,520 | - | - | Direct |
| Mar 21, 2023 | CMMB Chemomab Therapeutics Ltd. | Award Stock option (right to buy American Depositary Shares) | 1,714 | - | - | Direct |
| Mar 7, 2022 | CMMB Chemomab Therapeutics Ltd. | Award Stock option (right to buy American Depositary Shares) | 1,705 | - | - | Direct |
| Apr 19, 2021 | CMMB Chemomab Therapeutics Ltd. | Award Stock option (right to buy American Depositary Shares) | 2,971 | - | - | Direct |
| Jul 16, 2020 | CMMB Chemomab Therapeutics Ltd. | Award Stock option (right to buy American Depositary Shares) | 172 | - | - | Direct |
1-9 of 9 transactions